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Abstract Increased weakness during cold (cold paresis)
was reported in single cases of multifocal motor neuropa-
thy (MMN). This was unexpected because demyelination is
a feature of MMN and symptoms of demyelination
improve, rather than worsen, in cold. It was hypothesized
that cold paresis in MMN does not reﬂect demyelination
only, but may indicate the existence of inﬂammatory nerve
lesions with permanently depolarized axons that only just
conduct at normal temperature, but fail at lower tempera-
tures. We investigated symptoms of cold paresis in 50
MMN patients, 48 chronic inﬂammatory demyelinating
polyneuropathy (CIDP) patients, 35 progressive spinal
muscular atrophy (PSMA) patients, and 25 chronic idio-
pathic axonal polyneuropathy patients. We also investi-
gated symptoms of increased weakness during warmth
(heat paresis). Cold paresis was reported more often than
heat paresis. Cold paresis was most frequently reported in
MMN. Multivariate analysis indicated that MMN patients
had a 4- to 6-fold higher risk of reporting cold paresis
than CIDP or PSMA patients. Because cold paresis is not
consistent with demyelination, the lesions in MMN may
involve other mechanisms than demyelination only. In
conclusion, symptoms of cold paresis are common in
peripheral nervous system disorders, particularly in MMN.
This supports the above-described hypothesis.
Keywords Multifocal motor neuropathy  Chronic
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muscular atrophy  Cold paresis
Abbreviations
CB Conduction block
CIAP Chronic idiopathic axonal polyneuropathy
CIDP Chronic inﬂammatory demyelinating
polyneuropathy
MMN Multifocal motor neuropathy
PSMA Progressive spinal muscular atrophy
Introduction
The effect of temperature on symptoms of neurological
disorders is complicated and has not been fully explored,
neither in patients, nor in physiological research. A well-
known effect is the worsening of symptoms in multiple
sclerosis after a hot bath [20, 25]. In peripheral neuropa-
thies, similar effects were described. In a patient with
chronic inﬂammatory demyelinating polyneuropathy
(CIDP), symptoms considerably increased during fever and
in seven patients with various demyelinating neuropathies,
electrophysiological signs of conduction block increased
after warming and decreased after cooling [4, 8, 20]. This
so-called heat paresis may occur in demyelinating disor-
ders and is caused by an unfavorable combination of fac-
tors that block saltatory conduction between an active node
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DOI 10.1007/s00415-010-5712-3of Ranvier and the node that is next to be activated. First,
paranodal demyelination results in current leakage at the
node-to-be-activated, so that less current is available to
depolarize this node [11]. Secondly, raising temperature
will decrease sodium-channel open time at the active node
[6, 21]. This yields a further decrease in the current
available to depolarize the node-to-be-activated. If there is
just sufﬁcient current available to sustain action potential
propagation at a demyelinated internode, an additional
decrease in current due to rising temperature may, there-
fore, induce conduction block as was shown in single
demyelinated internodes [19].
In the authors’ experience, however, patients with
peripheral nervous system disorders often state that
weakness during cold increases. This cold paresis is not
consistent with the above-described mechanism because
that would lead to less weakness in cold. Whether or not
cold paresis is really common and if it is related to speciﬁc
disorders has not been investigated. Furthermore, the
mechanisms of cold paresis are not clear. Cold paresis was
only reported in single cases of multifocal motor neurop-
athy (MMN) and in patients with Hirayama disease [11,
23]. To explain cold paresis in MMN, Kaji hypothesized
the existence of inﬂammatory nerve lesions with perma-
nently depolarized axons that only just conduct at normal
temperature [11]. At lower temperatures, Na/K-pump
activity decreases due to the thermal reduction of its ATP-ase
activity; this may cause additional depolarization, yielding
depolarizing conduction block and weakness [9–11].
Recent ﬁndings from our group supported the hypothesis of
Kaji by showing that cooling indeed induced depolariza-
tion of human motor axons, and that this depolarization
was best explained by decreased pump-activity [7]. Since,
in the future, such axons may possibly be saved from
degeneration by neuroprotective treatment, cold paresis
may become an important symptom [13, 22, 30].
The present study was not conducted to investigate the
mechanism of cold paresis but to assess if symptoms of
cold paresis are common in MMN and if they are speciﬁc
for MMN. If cold paresis were a common symptom, it may
instigate further research into its mechanisms. If cold
paresis were speciﬁc for MMN, it may form a clue for the
pathogenesis of MMN, which is currently unknown. We
investigated the frequency of symptoms of cold paresis and
heat paresis in a large group of patients with MMN. Con-
trol groups included CIDP, sporadic progressive spinal
muscular atrophy (PSMA), and chronic idiopathic axonal
polyneuropathy (CIAP).
Materials and methods
Patients
A cross-sectional study was performed by sending a ques-
tionnaire to 60 patients with MMN, 60 with CIDP, 50 with
sporadicPSMA, and 35patientswith CIAP. Allpatientshad
weakness in arm or leg muscles on neurological examina-
tion. The questionnaire was returned by 83% of MMN, 80%
ofCIDP,70%ofPSMA,and71%ofCIAPpatients.Foreach
group, the patients who did not return the questionnaire did
not differ signiﬁcantly from the patients who returned the
questionnaire with respect to sex, age, and disease duration
(data not shown). Patient characteristics are presented in
Table 1. Two patients in the PSMA group had Hirayama
disease. The patients attended the outpatient clinics of the
University Medical Center in Utrecht, a tertiary referral
center for neuromuscular disorders in the Netherlands.
Diagnoses were based on criteria sets for MMN [28], CIDP
[1], sporadic PSMA [29], and CIAP [16]. In these sets, the
criteria for conduction block were adapted [27, 28]. All
MMNpatientswereonintravenousimmunoglobulins(IVIg)
maintenance treatment. Twenty-eight patients with CIDP
were treated with IVIg, with 20 patients responding favor-
ably. Twelve patients with CIDP were treated with steroids,
with 11 patients responding favorably. Of the remaining
CIDP patients, two were successfully treated with cyclo-
phosphamide and six were not treated. None of the patients
hadconcomitantdiseasesofthecentralorperipheralnervous
system.Allparticipantsgaveinformedconsenttoparticipate
in the study, which was approved by the Medical Ethical
Committee of the University Medical Center Utrecht.
Table 1 Baseline characteristics
Patient group Male
(%)
Age
(years)
Disease duration
(years)
Weakness
arm (%)
Weakness
leg (%)
CB arm
nerves (%)
CB leg
nerves (%)
MMN (n = 50) 82 51 (33–74) 10 (2–39) 100 68 68 24
CIDP (n = 48) 58 54 (22–82) 4 (0–32) 88 96 44 19
PSMA (n = 35) 86 61 (35–83) 12 (4–30) 86 51 0 0
CIAP (n = 25) 80 75 (61–89) 13 (4–21) 28 100 0 0
Age and disease duration are given as median (range)
CB conduction block; MMN multifocal motor neuropathy; CIDP chronic inﬂammatory demyelinating polyneuropathy; PSMA progressive spinal
muscular atrophy; CIAP chronic idiopathic axonal polyneuropathy
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123The results of the last nerve conduction studies, per-
formed prior to the questionnaire, were reviewed for
presence of deﬁnite conduction block (segmental reduction
in negative compound muscle action potential area of at
least 50% in any nerve) and probable conduction block
(segmental reduction in negative compound muscle action
potential amplitude of at least 30% in an arm nerve) [27].
Conduction studies included the median nerve (recording
from the thenar and ﬂexor carpi radialis muscle), ulnar
nerve, radial nerve, and musculocutaneous nerve up to
Erb’s point, and the peroneal and tibial nerves up to the
knee [27]. These nerves were studied bilaterally, except for
ﬁve patients with CIDP and the patients with CIAP who
were studied unilaterally. Conduction block in arm or leg
nerves was found in all MMN patients, in 82% of CIDP
patients, and in none of the PSMA or CIAP patients
(Table 1). MMN patients had conduction block in arm
nerves more often than CIDP patients.
Questionnaire
The questionnaire consisted of temperature-related and
weakness-related items. Questions concerned the year
preceding the questionnaire to reduce recall bias. First, we
asked if symptoms of weakness and conditions of cooling
or warming had occurred. Conditions of cooling included a
stay in cold weather, the use of cold packs or taking a cold
shower, bath or swim. Conditions of warming included a
stay in hot weather, the use of hot packs or electric blan-
kets, rinsing the hands in hot water while washing dishes or
taking a warm or hot shower, bath or swim. If symptoms of
weakness and conditions of cooling or warming had
occurred, we asked if weakness increased during cooling
(cold paresis) or warming (heat paresis). Exposure to
cooling or warming and increase in weakness were entered
as dichotomous variables. Prior to the study, the ques-
tionnaire was tested for inconsistencies and feasibility by a
randomly chosen sample of 20 patients who visited our
outpatient clinic for neuromuscular disorders with symp-
toms of weakness and who were not included in this study.
Statistical analysis
We calculated the frequency of symptoms of cold (or heat)
paresis in arms with established weakness and in legs with
established weakness. We determined if: (1) exposure to
cooling and warming differed between patient groups, and
(2) the percentage of patients with CIDP, PSMA, or CIAP
reporting symptoms of cold or heat paresis differed from
the percentage of patients with MMN reporting symptoms
of cold or heat paresis (Chi-square tests).
Next, univariate and multivariate binary logistic
regression analyses were performed. The determinant of
interest was presence of MMN with CIDP, PSMA, and
CIAP as reference groups. Outcome variables included: (1)
symptoms of cold paresis in arms or legs, (2) symptoms of
cold paresis in arms, (3) symptoms of cold paresis in legs,
(4) symptoms of heat paresis in arms or legs, (5) symptoms
of heat paresis in arms, and (6) symptoms of heat paresis in
legs. Age and disease duration were assessed as continuous
variables. The possible confounders sex, age (in years), and
disease duration (in years) at the time of the questionnaire
were added in the multivariate models.
Version 15.0.1 of the SPSS statistical software program
(Chicago, IL, USA) was used for all analyses. p values
\0.05 were considered to be signiﬁcant.
Results
Exposure to cooling or warming did not differ signiﬁcantly
between MMN, CIDP, and PSMA, but CIAP patients were
signiﬁcantly less often exposed to cooling than MMN and
Table 2 Percentage of patients exposed to cooling
Patient group Any Bathing Weather Swimming Cold pack
MMN 96 20 96 30 20
CIDP 90 23 88 29 8
PSMA 97 17 97 26 9
CIAP 72 8 72 8 4
MMN multifocal motor neuropathy; CIDP chronic inﬂammatory
demyelinating polyneuropathy; PSMA progressive spinal muscular
atrophy; CIAP chronic idiopathic axonal polyneuropathy
Table 3 Percentage of patients exposed to warming
Patient group Any Bathing Weather Sauna Hot pack Electric blanket Dish-washing
MMN 100 90 82 26 12 22 62
CIDP 98 92 90 19 2 13 65
PSMA 97 97 80 20 3 14 54
CIAP 96 76 60 0 0 20 52
MMN multifocal motor neuropathy; CIDP chronic inﬂammatory demyelinating polyneuropathy; PSMA progressive spinal muscular atrophy;
CIAP chronic idiopathic axonal polyneuropathy
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123PSMA patients (Tables 2, 3). Exposure to warming was
more common than exposure to cooling and cold weather
was the most common exposure to cooling. Despite this,
patients reported cold paresis more often than heat paresis
(Table 4).
Cold paresis in arms or legs was reported more fre-
quently in MMN than in CIDP, PSMA, and CIAP (Table 4).
Multivariate analysis showed that these differences were
independent of sex, age, and disease duration, except for
CIAP (Table 5). Patients with MMN had a ﬁvefold higher
risk of symptoms of cold paresis than patients with CIDP,
and a sixfold higher risk than patients with PSMA. Multi-
variate analysis for symptoms of cold paresis in arms and
legs separately, showed that these differences were still
signiﬁcant for the arms but not for the legs (Table 5).
Heat paresis in arms or legs was not signiﬁcantly more
or less frequently reported in MMN than in CIDP, PSMA
and CIAP (Table 4). Neither univariate nor multivariate
analysis showed any signiﬁcant differences between MMN
and the other patient groups (data not shown).
Discussion
The present study demonstrated that cold paresis was
experienced by a substantial proportion of patients with
MMN, CIDP, PSMA, and CIAP. Cold paresis was more
frequently reported than heat paresis. Cold paresis was
more frequently reported in MMN than in CIDP, PSMA, or
CIAP. Multivariate analysis indicated that MMN patients
had a 4- to 6-fold greater risk of experiencing cold paresis
than CIDP or PSMA patients. Because MMN predomi-
nantly affects arm nerves [27], we analyzed symptoms of
cold paresis in arms and legs separately; this showed that
these differences were still signiﬁcant for the arms but not
for the legs.
In MMN, electrophysiological, pathological, and
immunological studies suggest that several mechanisms
may be involved in the unique process that results in
asymmetric loss of strength and muscular atrophy. Motor
nerve conduction studies may show conduction block and
slowing consistent with demyelination in the same seg-
ment; however, conduction velocity may also be normal in
segments with motor conduction block [27, 28]. Some
pathological studies of nerve branches containing motor
and sensory axons showed demyelination but others only
showed loss of axons [2, 5, 12, 24]. Needle electromyog-
raphy studies showed extensive neurogenic abnormalities
in non-atrophic as well as in atrophic muscles [26].
Excitability studies showed focal depolarization or hyper-
polarization of motor axons of which the signiﬁcance is not
clear [14, 17]. In many MMN patients, antibodies against
epitopes presented on the axolemma are found, and a
recent study showed that these anti-GM1 antibodies are
associated with loss of motor axons [3]. Thus, whereas
demyelination clearly occurs in MMN, mechanisms lead-
ing to primary axonal degeneration may possibly occur as
well. It is not clear if the conduction block is due to
unfavorable effects of paranodal demyelination, blocking
of impulse generation at the node, or both. Because MMN
may lead to demyelination as well as loss of motor axons,
we have chosen CIDP, PSMA, and CIAP as control groups
in order to make a comparison to peripheral nervous sys-
tem disorders that are also characterized by weakness:
CIDP is characterized mainly by demyelination of motor
Table 4 Percentage of patients reporting cold and heat paresis
Patient group Cold paresis p value Heat paresis p value
MMN 83 – 18 –
CIDP 44 \0.001 26 ns
PSMA 50 0.001 6 ns
CIAP 44 0.002 17 ns
p values refer to comparison with MMN
MMN multifocal motor neuropathy; CIDP chronic inﬂammatory
demyelinating polyneuropathy; PSMA progressive spinal muscular
atrophy; CIAP chronic idiopathic axonal polyneuropathy; ns not
signiﬁcant
Table 5 Risk of cold paresis in MMN versus other disorders
Patient groups Arm and leg Odds ratio p value Arm Odds ratio p value
MMN–CIDP Univariate 6.3 (2.4–16.6) \0.001 Univariate 6.9 (2.4–20.0) \0.001
Multivariate 4.7 (1.7–13.4) 0.003 Multivariate 5.3 (1.7–16.7) 0.005
MMN–PSMA Univariate 5.0 (1.8–13.8) 0.002 Univariate 3.4 (1.1–10.3) 0.03
Multivariate 5.7 (1.8–18.1) 0.003 Multivariate 3.8 (1.04–14.3) 0.04
MMN–CIAP Univariate 6.3 (1.9–20.8) 0.003
Multivariate 4.0 (0.4–36.5) ns
Odds ratios are given with 95% conﬁdence intervals. Multivariate analysis was adjusted for age, sex, and disease duration. Cold paresis in arm
muscles in the CIAP group was not analyzed because only two patients had upper limb weakness and were exposed to cold
MMN multifocal motor neuropathy; CIDP chronic inﬂammatory demyelinating polyneuropathy; PSMA progressive spinal muscular atrophy;
CIAP chronic idiopathic axonal polyneuropathy; ns not signiﬁcant
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123and sensory axons, PSMA by loss of motor axons, and
CIAP by length-dependent loss of motor and sensory
axons.
Cold paresis was reported by two-thirds of patients with
distal upper limb muscular atrophy (Hirayama disease), a
disorder affecting peripheral motor neurons in the anterior
horn of the cervical cord, which results in denervation of
hand muscles [23]. Nerve conduction studies in 11 patients
with Hirayama disease, and one patient with hypothenar
atrophy due to ulnar neuropathy, showed that cold induced
excessive conduction delay and waning of the compound
muscle action potential during 20-Hz repetitive stimulation
[15, 18]. These ﬁndings were attributed to an increased
sensitivity of reinnervated muscle ﬁbers to develop depo-
larizing conduction block in cold.
Cold paresis in MMN was suggested to be related to the
existence of inﬂammatory nerve lesions where axons are
depolarized but just able to conduct impulses at ambient
temperature [11]. At these lesions, thermal reduction of Na/
K-pump activity due to cooling may induce further depo-
larization to a point where impulse conduction fails. Some
ﬁndings may support this hypothesis. First, animal models
of inﬂammatory spinal root lesions indicated that inﬂam-
mation may induce nitric oxide-mediated mitochondrial
dysfunction, energy depletion of the ATP-ase dependent
Na/K-pump, and axonal depolarization [13]. Secondly,
excitability studies in MMN indirectly suggested that
axons at the site of block may possibly be depolarized
[14, 17]. Thirdly, cooling of normal human motor axons
results in their depolarization, probably due to decreased
Na/K-pump activity [7]. Some of the steps in this
hypothesis were corroborated by experiments, but it must
be emphasized, however, that its entire sequence has not
been proven. Moreover, some experiments were carried out
in central nervous system neurons so that the results pos-
sibly cannot be extrapolated to peripheral motor neurons.
Alternatively, cold paresis in MMN may be caused by
development of conduction block in reinnervated muscle
ﬁbers due to the lower temperature [15, 18]. The possibility
that this mechanism, which may be similar to that descri-
bed in Hirayama disease, occurs in MMN is supported by
several studies. Extensive needle electromyography studies
in MMN patients showed signs of reinnervation, indicating
collateral sprouting, in non-atrophic as well as in atrophic
muscles [26]. Some pathological studies of motor nerves in
MMN have shown prominent loss of axons and little
demyelination; the loss of axons may lead to collateral
sprouting and reinnervated muscle ﬁbers [24].
In conclusion, symptoms of cold paresis occur in several
peripheral nervous system disorders, but are consider-
ably more common in MMN. Because the present study
only assessed subjective symptoms of weakness, it is
worthwhile to investigate if cold also induces an objective
increase of weakness in MMN.
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